Morgan Stanley’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $155K | Buy |
|
|||||
|
2025
Q1 | $164K | Sell |
|
|||||
|
2024
Q4 | $2.91M | Buy |
|
|||||
|
2024
Q3 | $860K | Sell |
|
|||||
|
2024
Q2 | $2.69M | Sell |
|
|||||
|
2024
Q1 | $6.37M | Sell |
|
|||||
|
2023
Q4 | $13.8M | Buy |
|
|||||
|
2023
Q3 | $12.1M | Buy |
|
|||||
|
2023
Q2 | $12.9M | Buy |
|
|||||
|
2023
Q1 | $3.48M | Sell |
|
|||||
|
2022
Q4 | $5.65M | Buy |
|
|||||
|
2022
Q3 | $6.74M | Sell |
|
|||||
|
2022
Q2 | $5.89M | Buy |
|
|||||
|
2022
Q1 | $7.57M | Buy |
|
|||||
|
2021
Q4 | $6.44M | Sell |
|
|||||
|
2021
Q3 | $6.92M | Sell |
|
|||||
|
2021
Q2 | $8.64M | Sell |
|
|||||
|
2021
Q1 | $10M | Buy |
|
|||||
|
2020
Q4 | $10M | Buy |
|
|||||
|
2020
Q3 | $4.56M | Buy |
|
|||||
|
2020
Q2 | $4.07M | Buy |
|
|||||
|
2020
Q1 | $422K | Sell |
|
|||||
|
2019
Q4 | $4.48M | Buy |
|
|||||
|
2019
Q3 | $2.7M | Buy |
|
|||||
|
2019
Q2 | $1.28M | Buy |
|
|||||
|
2019
Q1 | $570K | Sell |
|
|||||
|
2018
Q4 | $753K | Sell |
|
|||||
|
2018
Q3 | $1.67M | Sell |
|
|||||
|
2018
Q2 | $4.12M | Buy |
|
|||||
|
2018
Q1 | $2.16M | Buy |
|
|||||
|
2017
Q4 | $747K | Buy |
|
|||||
|
2017
Q3 | $756K | Sell |
|
|||||
|
2017
Q2 | $874K | Buy |
|
|||||
|
2017
Q1 | $1.26M | Sell |
|
|||||
|
2016
Q4 | $4.11M | Buy |
|
|||||
|
2016
Q3 | $1.52M | Buy |
|
|||||
|
2016
Q2 | $33K | Sell |
|
|||||
|
2016
Q1 | $750K | Buy |
|
|||||
|
2015
Q4 | $83K | Sell |
|
|||||
|
2015
Q3 | $310K | Buy |
|
|||||
|
2015
Q2 | $276K | Buy |
|
|||||
|
2015
Q1 | $30K | Sell |
|
|||||
|
2014
Q4 | $959K | Buy |
|